Patent · US Expired

Chronic fatigue syndrome diagnosis

US6207366A · kind A · utility

2Cited by
4References
15Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 13, 2000
Grant dateMar 27, 2001
Priority date—
Expiry dateApr 13, 2020

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/573
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Chronic fatigue syndrome is diagnosed through quantification of low and high molecular weight forms of RNase L in cellular extracts of RNase L-containing cells such as peripheral blood mononuclear cells. A ratio of low to high molecular weight RNase L of more than 0.15 is characteristic of chronic fatigue syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.